Joint Pain News and Research

RSS
Mycophenolate mofetil is effective for managing symptoms of the most common type of lupus

Mycophenolate mofetil is effective for managing symptoms of the most common type of lupus

Walking fast after stroke improves rehabilitation

Walking fast after stroke improves rehabilitation

Research shows specific damage to nervous system in veterans with Gulf War syndrome

Research shows specific damage to nervous system in veterans with Gulf War syndrome

Cancer drug effective at treating lupus

Cancer drug effective at treating lupus

Study looks at the patient-practitioner relationship in complementary and alternative therapies

Study looks at the patient-practitioner relationship in complementary and alternative therapies

Osteoarthritis twice as likely if parents suffer the condition

Osteoarthritis twice as likely if parents suffer the condition

Study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

Study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

A new marker for osteoarthritis

A new marker for osteoarthritis

New clinical study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

New clinical study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

A third of U.S. adults use some form of complementary and alternative medicine

A third of U.S. adults use some form of complementary and alternative medicine

Facts about prevalence of arthritis in the U.S.A

Facts about prevalence of arthritis in the U.S.A

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.